Del OTC Acquisition Brings Orajel To Church & Dwight In $380 Million Deal
This article was originally published in The Tan Sheet
Executive Summary
Church & Dwight agreed to acquire Del Pharmaceuticals' OTC brands, including the Orajel topical analgesic line, for $380 million in cash from Coty, Inc., the firm said April 1